★★★★☆
4.6 étoiles sur 5 de 785 notations client
Parkinson's Disease in the Older Patient (English Edition) - de Dr Jeremy R Playfer (Author)
Details Parkinson's Disease in the Older Patient (English Edition)
Les données suivantes sont affichées les caractéristiques détaillées sur Parkinson's Disease in the Older Patient (English Edition)
| Le Titre Du Livre | Parkinson's Disease in the Older Patient (English Edition) |
| Date de publication | |
| Traducteur | Shamari Sunah |
| Numéro de Pages | 271 Pages |
| La taille du fichier | 78.42 MB |
| Langue du Livre | Français et Anglais |
| Éditeur | Kids Can Press |
| ISBN-10 | 5910018987-XFQ |
| Format de eBook | AMZ PDF EPub AMI XMDF |
| Écrivain | Dr Jeremy R Playfer |
| Digital ISBN | 054-0248513652-DPV |
| Nom de Fichier | Parkinson's-Disease-in-the-Older-Patient-(English-Edition).pdf |
Télécharger Parkinson's Disease in the Older Patient (English Edition) Livre PDF Gratuit
Parkinsons Disease in the Older Patient Second Edition has been fully revised updated and expanded to include new treatments and entirely new chapters
The prevalence of Parkinsons disease is 15 after the age of 65 and in elderly patients it is often associated with other disorders which effect motivity
Parkinson’s disease is the world’s second most common neurodegenerative disorder behind Alzheimer’s disease While it’s unknown exactly why people develop the condition according to
Découvrez et achetez Parkinsons Disease A Complete Guide for Patients and Families
Je découvre Parkinson – Une brochure d’une quarantaine de pages sous forme de questions réponses pour comprendre la maladie et ses spécificités les traitements proposés et mieux vivre au quotidien Cette brochure s’adresse aux personnes nouvellement diagnostiquées et leurs proches
Parkinsons ailment is a continual modern ailment of the imperative apprehensive equipment that belongs to a collection of circumstances called motor equipment themes
A new study reports that hepatitis C patients treated with antiviral medication were less likely to develop Parkinsons disease compared with those not receiving such therapy